PECULIARITIES OF CLINICAL AND INSTRUMENTAL INDICATORS OF COMMUNITY-ACCOMPANY PNEUMONIA WITH MYOCARDITIS IN CHILDREN
Keywords:
pneumonia, myocarditis, children, echocardiography, analysisAbstract
Worldwide, pneumonia is the leading cause of morbidity and mortality in children under 5 years of age. Although the majority of childhood pneumonia-related deaths occur primarily in developing countries, the disease burden is substantial and there are significant public health costs associated with pneumonia in developed countries. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. High levels of CK-MB were found in all patients who died and in six out of seven patients with congestive heart failure. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. High levels of CK-MB were found in all patients who died and in six out of seven patients with congestive heart failure. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. The paper presents the results of anamnestic, clinical, conventional laboratory and special methods of examination in 80 children with community-acquired pneumonia aged 1 to 6 years, of which 40 patients with concomitant myocarditis who were hospitalized in departments II of emergency pediatrics and children's resuscitation of Samarkand branch of the Republican Scientific Center for Emergency Medical Care in the period from 2020 to 2022.
References
Fonseca T.S., Vasconcellos A.G., Gendrel D., et al. Recovery from childhood community-acquired pneumonia in a developing country: prog-nostic value of serum procalcitonin//Clin. Chim. Acta. - 2019 - Vol. 489 - p. 212-218.
Чаулин А.М., Мазаев А.Ю., Григорьева Е.В., Нурбалтаева Д.А., Александров А.Г. Клинико-диагностическое значение определения кардиальных тропонинов в крови при сепсисе и септическом шоке (обзор литературы) // Евразийское Научное Объединение. 2019. № 2-2 (48). С. 113-116.
Пшеничная Е. В. и др. Острый миокардит у детей: проблемы диагностики и лечения //Педиатр. – 2020. – Т. 11. – №. 1.
Хакимова Л., Лапасов С. Особенности течения пневмоний у детей раннего возраста //InterConf. – 2020.
Закирова Б. И., Мамаризаев И. К. Течение рецидивирующих респираторных инфекций у детей на фоне атопического дерматита. Ж //Вопросы науки и образования. – 2021. – Т. 9. – С. 134.
Закирова Б. И. и др. Бронхообструктивный синдром: прогностическая значимость дисбиоза кишечника в его развитии //Достижения науки и образования. – 2020. – №. 10 (64). – С. 83-85.
Зиядуллаев С. и соавт. ЛБПС 02-60 КОМБИНИРОВАННАЯ АНТИГИПЕРТЕНЗИВНАЯ ТЕРАПИЯ В ЛЕЧЕНИИ АГ ПРИ МЕТАБОЛИЧЕСКОМ СИНДРОМЕ //Журнал гипертонии. – 2016. – Т. 34. – С. е522.
Шодикулова Г. З., Элламонов С. Н., Насирова А. А. Частота встречаемости дилатационной кардиомиопатии в узбекской популяции //Вестник науки и образования. – 2020. – №. 13-2 (91). – С. 44-48.
Nasirova A. A. et al. Features Of Immunological Indicators In Patients With Chronic Obstructive Lung Disease And Bronchial Asthma //Solid State Technology. – 2020. – Т. 63. – №. 6. – С. 6873-6880.
Nasirova A. FEATURES OF MAIN CLINICAL MANIFESTATIONS AND QUALITY OF LIFE IN COPD AND BA PATIENTS //InterConf. – 2021.
